Upstream Sex and Gender Integration Marker
This Upstream Marker for Health is a learning tool for the foundation’s upstream health investments. It is intended to be used by investment owners when designing and refining an investment and to spark conversation with grantees.
The purpose of this tool is to enable investment owners and teams to more intentionally integrate relevant considerations on sex as a biological variable and other sociodemographic characteristics.
Download Upstream Marker for Health
For additional resources and learning, see below a non-exhaustive selection of materials including self-paced e-learning.
Resources
Additional Resources
- Design, Analyze and Communicate (DAC) resource: Points to Consider for integrating sex and gender in clinical trials. DAC is an available resource for Gates Foundation grantees undergoing clinical trials. Learn more about DAC.
- Women’s Health Innovation Opportunity Map 2023: Issued by the Innovation Equity Forum, a group of 250+ experts and stakeholders in women’s health R&D.
- SAGER Guidelines for human and non-human studies
- Sex Inclusive Research Framework: An evaluation tool to assess in vivo research proposals for sex inclusive approach.
- NIH’s Sex as a Biological Variable (SABV) policy.
- Health Canada’s Sex and Gender-Based Analysis Plus.
- European Medicines Agency (EMEA) resource on clinical trials.
- FDA’s Evaluation of Sex-Specific Data in Medical Device Clinical Studies.
Self-service learning
Canada’s Institute of Gender and Health offers free, open access and interactive training modules to integrate sex and gender across health research.